- Home
- SIBN
SIBN
SI-BONE Inc.
as 04-18-2025 1:43pm EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 567.6M | IPO Year: | 2018 |
| Target Price: | $24.40 | AVG Volume (30 days): | 384.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.70 - $19.16 | Next Earning Date: | 05-05-2025 |
| Revenue: | $167,178,000 | Revenue Growth: | 20.37% |
| Revenue Growth (this year): | 18.52% | Revenue Growth (next year): | 16.39% |
Stock Insider Trading Activity of SI-BONE Inc. (SIBN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Apr 2 '25 | Sell | $14.15 | 3,311 | $46,852.55 | 286,112 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Apr 2 '25 | Sell | $14.11 | 3,311 | $46,723.49 | 270,293 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Apr 2 '25 | Sell | $14.04 | 3,128 | $44,219.05 | 247,972 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Feb 18 '25 | Sell | $16.82 | 9,531 | $160,732.37 | 286,112 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Feb 18 '25 | Sell | $16.94 | 11,180 | $188,518.22 | 270,293 | |
| DUNN JEFFREY W | SIBN | Director | Feb 18 '25 | Sell | $16.77 | 1,619 | $27,151.60 | 15,191 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Feb 18 '25 | Sell | $17.03 | 46,233 | $795,914.58 | 516,809 | |
| DUNN JEFFREY W | SIBN | Director | Feb 3 '25 | Sell | $16.51 | 337 | $5,562.39 | 15,191 |
Latest SI-BONE Inc. News
SIBN Breaking Stock News: Dive into SIBN Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
MT Newswires
8 days ago
Truist Cuts Price Target on SI-BONE to $20 From $22, Keeps Buy Rating
Zacks
9 days ago
IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last?
TipRanks
2 months ago
SI-Bone price target raised to $24 from $20 at Needham
Simply Wall St.
2 months ago
SI-BONE Full Year 2024 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
2 months ago
Q4 2024 SI-BONE Inc Earnings Call
MT Newswires
2 months ago
Truist Securities Adjusts SI-BONE Price Target to $22 From $18, Maintains Buy Rating
GuruFocus.com
2 months ago
SI-BONE Inc (SIBN) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Positive EBITDA
Compare SIBN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.